NIH-funded research
Executive Summary
Senate Commerce/Science Subcommittee Chairman Ron Wyden (R-Ore.) no longer plans hearings or legislation to address the return to taxpayers from research funded by the National Institutes of Health. Wyden met Oct. 10 with reps from NIH, the pharmaceutical industry and research institutions. Wyden is understood to be satisfied by NIH's plan to begin implementation of a web-based database of approved drugs that use technology funded by NIH and to use standardized language to simplify reporting requirements by Jan. 1 (1"The Pink Sheet" Aug. 27, p. 3)